Showing results (811-820 of 928) with videos related to

Sort By:
Pageof 93
The Lancet. Diabetes & Endocrinology|September 21, 2017
Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trialMarc S Sabatine, Lawrence A Leiter, Stephen D Wiviott, et al.
The Lancet. Diabetes & Endocrinology|September 3, 2017
Association of dietary nutrients with blood lipids and blood pressure in 18 countries: a cross-sectional analysis from the PURE studyAndrew Mente, Mahshid Dehghan, Sumathy Rangarajan, et al.
The Lancet. Diabetes & Endocrinology|March 10, 2018
Clinical efficacy and safety of a light mask for prevention of dark adaptation in treating and preventing progression of early diabetic macular oedema at 24 months (CLEOPATRA): a multicentre, phase 3, randomised controlled trialSobha Sivaprasad, Joana C Vasconcelos, A Toby Prevost, et al.
The Lancet. Diabetes & Endocrinology|March 3, 2018
Effect of fenofibrate on uric acid and gout in type 2 diabetes: a post-hoc analysis of the randomised, controlled FIELD studyBoris Waldman, Jean-Claude Ansquer, David R Sullivan, et al.
The Lancet. Diabetes & Endocrinology|March 6, 2018
Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variablesEmma Ahlqvist, Petter Storm, Annemari Käräjämäki, et al.
The Lancet. Diabetes & Endocrinology|November 14, 2017
Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort studyGregory L Hundemer, Gary C Curhan, Nicholas Yozamp, et al.
The Lancet. Diabetes & Endocrinology|December 12, 2018
Use of liraglutide and risk of major cardiovascular events: a register-based cohort study in Denmark and SwedenHenrik Svanström, Peter Ueda, Mads Melbye, et al.
The Lancet. Diabetes & Endocrinology|November 3, 2019
Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension studyMichael R McClung, Michelle L O'Donoghue, Socrates E Papapoulos, et al.
The Lancet. Diabetes & Endocrinology|November 4, 2019
Gastric bypass versus sleeve gastrectomy in patients with type 2 diabetes (Oseberg): a single-centre, triple-blind, randomised controlled trialDag Hofsø, Farhat Fatima, Heidi Borgeraas, et al.
The Lancet. Diabetes & Endocrinology|August 10, 2014
Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort studyNita G Forouhi, Albert Koulman, Stephen J Sharp, et al.
Pageof 93